Guardant Health

To help doctors cure cancer patients and provide a better life through non invasive liquid biopsy analysis of cell free dna.

Founded 2012
51-200 employees
  • Health Care Technology & Nursing
  • Headquarters address
    2686 Middlefield Road, Redwood City, CA 94063, USA

    In the late 1990’s, Dr. Maurice Stroun first discovered that tumors continually shed their unique genomic material – the root cause of most cancers – into the bloodstream. Unfortunately, these telltale genomic “signals” are so weak that current genomic analysis technologies, including next-generation sequencing, can only detect such signals sporadically or in patients with terminally high tumor burden. The main reason for this is that such technologies are plagued by error rates and bias that can be orders of magnitude higher than what is required to reliably detect de novo genomic alterations associated with cancer.

    Guardant Health has leveraged these same advances in digital communication to develop a genomic analysis technology architecture called Digital Sequencing. This architecture reduces the noise and distortion generated by next-generation sequencing to almost zero. Digital Sequencing enables ultra high-fidelity, single-molecule detection of actionable tumor-specific genomic alterations in cancer with unparalleled specificity and breadth. Put another way, clinicians using Guardant Health’s technology can now non-invasively see the genomic dimension of cancer throughout a patient.

    Tech stack

    Rails 4 MySQL Docker Amazon Elastic Beanstalk Amazon EC2 d3.js Coffeescript SCSS/SASS RSpec/Capybara TDD Living style guides

    Benefits

    Compensation and retirement

    401k

    Health and wellness

    Health insurance
    Dental insurance
    Vision insurance
    Life insurance
    Disability insurance

    Values and quality of life

    Catered lunches